© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
August 01, 2021
Joseph Sullivan, MD, and Elaine C. Wirrell, discuss the transition of care into adulthood of patients with Dravet syndrome.
Key opinion leaders discuss managing patient expectations regarding clinical trials for Dravet syndrome treatment.
July 25, 2021
A discussion of new developments for the treatment of Dravet syndrome beyond seizure control including gene editing and therapy.
The impact of new drug approvals on the consensus guidelines for the treatment of Dravet syndrome.
July 19, 2021
The panelists discuss the possibility of treating Dravet syndrome in older children and adults and the effects if the therapies were effective.
The panel discusses future gene therapies in development for Dravet syndrome.
July 13, 2021
Joseph Sullivan, MD, provides an overview of the recent approval of fenfluramine oral solution for the treatment of Dravet syndrome.
Elaine C. Wirrell, MD, provides an overview of cannabidiol oral solution for treatment of seizures associated with Dravet syndrome.
July 07, 2021
Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the management of seizures for Dravet syndrome with different approved therapies.
Experts discuss the goals of treatment of patients with Dravet syndrome regarding seizure freedom and seizure burden.